Ultrasound Guided Paravertebral Block Versus Erector Spinae Block for Postoperative Analgesia After Inguinal Hernia Repair in Pediatric Patients
1 other identifier
interventional
158
1 country
2
Brief Summary
The aim of the study is to compare postoperative analgesia in pediatric patients undergoing inguinal hernia repair by comparing the efficacy of ultrasound guided paravertebral block versus ultrasound guided erector spinae plane block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2024
CompletedFirst Posted
Study publicly available on registry
December 30, 2024
CompletedStudy Start
First participant enrolled
December 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJanuary 1, 2025
December 1, 2024
9 months
December 21, 2024
December 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The total amount of rescue analgesia (Ibuprofen consumption)
The total consumption of rescue analgesia (Ibuprofen consumption) postoperative
for 24 hours postoperative
Secondary Outcomes (5)
Pain intensity at rest (static) and after movement or coughing (dynamic)
0 minutes immediate postoperative ( on arrival to PACU), 30 minutes, 1hs, 2hs, 4hs, 8hs, 12 hrs and 24hs postoperatively
The time to first request of rescue analgesia (Ibuprofen)
for 24 hours postoperative
The total number of patients requiring additional dose of intraoperative fentanyl.
during operation period
To record the incidence of complications
24 hours postoperative
Over all parent's satisfaction
24 hours postoperative
Study Arms (3)
Group paravertebral (PVB) block
ACTIVE COMPARATORIn the lateral decubitus and after sterilization and identifying the level of T10 ,linear ultrasound probe will be placed in the midline over the spinous process at the chosen level, then the probe will be moved laterally to view the lamina and hyperechoic transverse process ,the pleural should be visible as a bright white line .The needle should be inserted in -plane from lateral to medial and the needle tip should end in a hypoechoic triangular space .Correct needle placement should be confirmed by anterior displacement of pleura with injection of small volume of saline then 0.5 ml/kg of a mixture of 0.25 ℅ bupivacaine and 1℅ lidocaine (1:1) will be injected
Group erector spinae plane (ESP) block
ACTIVE COMPARATORIn the lateral decubitus position ,after sterilization, the linear ultrasound probe will be placed over transverse process of T10 ,after optimizing the image in sagittal or transverse scanning ,A 50 mm 22-G needle will be placed under the erector spinae muscle in -in plane orientation until it contacted T8 transverse process in the cranial caudal direction ,after hydro dissection and confirmation that the tip of the needle is between the transverse process and the fascia of the erector spinae muscle group, 0.5 ml/kg of a mixture of 0.25 ℅bupivacaine and 1℅ lidocaine (1:1) will be injected and the surgery will be started after 15 min
Control group (group C)
ACTIVE COMPARATORwill receive standard general anesthesia with pain management protocol without regional block. Pain management protocol for all patients will include IV paracetamol 15 mg/kg every 6 hrs. (max dose for children \<50 kg is 60 mg/kg daily and if body weight ≥ 50 kg max dose is 4 gm daily) . Ibuprofen will be given as rescue analgesia 10 mg/kg IV if MOPS was \> 3 at rest or after movement and can be repeated every 6 hrs not exceeding 400 mg/dose and max daily dose 40 mg/kg.
Interventions
after sterilization and identifying the level of T10 ,linear ultrasound probe will be placed in the midline over the spinous process at the chosen level, then the probe will be moved laterally to view the lamina and hyperechoic transverse process ,the pleural should be visible as a bright white line .The needle should be inserted in -plane from lateral to medial and the needle tip should end in a hypoechoic triangular space. Correct needle placement should be confirmed by anterior displacement of pleura with injection of small volume of saline then 0.5 ml/kg of a mixture of 0.25 ℅ bupivacaine and 1℅ lidocaine (1:1) will be injected
After sterilization, the linear ultrasound probe will be placed over transverse process of T10 ,after optimizing the image in sagittal or transverse scanning ,A 50 mm 22-G needle will be placed under the erector spinae muscle in -in plane orientation until it contacted T8 transverse process in the cranial caudal direction ,after hydro dissection and confirmation that the tip of the needle is between the transverse process and the fascia of the erector spinae muscle group, 0.5 ml/kg of a mixture of 0.25 ℅bupivacaine and 1℅ lidocaine (1:1) will be injected
will receive standard general anesthesia with pain management protocol without regional block.
Eligibility Criteria
You may qualify if:
- Parents acceptance
- \. Age: preschool and school age child (24 months-12 years old).
- \. Sex: both sex (males or females).
- \. Physical status: ASA 1\& II.
- \. Type of operation: elective unilateral inguinal hernia repair
You may not qualify if:
- Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
- \. Patients with known history of allergy to the study drugs (bupivacaine and lidocaine).
- \. Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
faculty of human medicine, Zagazig university hospitals
El Sharkia, Egypt
Faculty of Human Medicine, Zagazig University
El Sharkia, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- anesthetist not sharing in the study will assess patients
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
December 21, 2024
First Posted
December 30, 2024
Study Start
December 30, 2024
Primary Completion
September 30, 2025
Study Completion
December 30, 2025
Last Updated
January 1, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share